Australia Computed Tomography Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

Market Overview

The Australia computed tomography market is a capital equipment and service business in which growth comes from replacement, upgrades and rising clinical use rather than from a large increase in installed units. Private radiology groups, public hospitals and regional providers buy scanners against Medicare-funded demand. Vendor service contracts and software licences add recurring revenue beyond the initial sale.

Three forces shape the outlook: low-dose CT screening for lung cancer, the arrival of photon-counting systems, and consolidation among private imaging groups that concentrates purchasing power and favours multi-site equipment agreements.

In July 2025 the National Lung Cancer Screening Program began, and in November 2025 Philips and Lumus Imaging announced six CT 5300 scanners in Queensland. In August 2026 Lumus Imaging launched photon-counting CT in Victoria.

Key Market Trends and Insights

• Screening demand: The Royal Australian College of General Practitioners reported in January 2026 that 49,473 people had enrolled in lung cancer screening by mid-December 2025.
• Early findings: The same January 2026 report said 560 people needed immediate further investigation after low-dose scans, which shows the programme adds diagnostic work downstream.
• Scan throughput: The National Cancer Screening Register reported more than 45,000 low-dose CT scans in the first six months, an average of 290 enrolments a day.
• Fee indexation: From 1 July 2026 the Medicare Benefits Schedule indexed most diagnostic imaging fees by 2.6%, supporting provider revenue and equipment budgets.

Australia Computed Tomography Market Size and Forecast

The market is moving from replacement of ageing multi-slice units towards higher-slice and spectral platforms, as screening, cardiac imaging and oncology staging raise expectations of image quality and speed. The 65 to 128-Slice class remains the workhorse, while Photon-Counting systems add the most value. Oncology holds the largest application share, with Cardiovascular imaging advancing fastest. Diagnostic imaging centres lead purchasing, and private hospitals gain share. New South Wales is the largest region and Queensland grows quickest. Equipment finance, service contracts and artificial intelligence software underpin a steady mid-single-digit outlook. Australian providers also weigh radiographer availability when scheduling replacements.

Key Takeaways: Australia Computed Tomography Market

Replacement and Screening Lift Revenue

Revenue is on course to expand by about 69% across the decade, from AUD 285.00 million in 2025 to AUD 482.23 million in 2035 at a 5.4% CAGR. Screening, indexed fees and equipment renewal make demand recurring.

Spectral Platforms and Private Providers Lead

Photon-Counting systems grow at an estimated 11.6% CAGR and private hospitals at an estimated 6.4% CAGR through 2035. Cardiovascular imaging advances at 7.2% as coronary and structural heart work moves onto CT.

Policy and Screening Shape Purchasing

Programme funding, fee indexation and consolidation of imaging groups influence when and where scanners are ordered. Vendors that pair hardware with software and service gain bargaining power. Equipment finance terms and service coverage increasingly decide tender outcomes in regional areas.

• Lung screening began in July 2025
• Imaging fees indexed by 2.6% from 1 July 2026
• Six Philips CT 5300 units announced in Queensland

Australia Computed Tomography Market Report Summary

Key Insight

Cancer screening, cardiac imaging and an ageing population sustain replacement cycles, while spectral technology lifts value per scanner. Private providers lead purchasing and the northern states grow fastest.

Key Trends in the Australia Computed Tomography Market

The Australia computed tomography market is being reshaped by national screening, photon-counting technology, indexed Medicare fees and ownership change among private imaging groups.

October 2026 - I-MED Radiology Joins a New Ownership Group

• On 1 October 2026 I-MED Radiology announced that it had joined Jardine Matheson, following a May 2026 agreement to acquire the network from Permira.
• I-MED operates one of the largest private radiology networks in Australia, so its capital planning influences multi-site CT purchasing.
• In February 2026 the group also expanded its clinician-led network through a radiology group acquisition.

August 2026 - Photon-Counting CT Reaches Victoria

• On 10 August 2026 Lumus Imaging described photon-counting CT at Knox Private Hospital as the first offering of the technology in Victoria.
• Lumus Imaging had previously launched the technology in New South Wales, and says it collects spectral data in every scan.
• The provider positions the system for musculoskeletal, cardiac and lung work and states it is not intended to replace conventional CT.

July 2026 - Medicare Updates Diagnostic Imaging Rules and Fees

• From 1 July 2026 schedule fees for most diagnostic imaging services were indexed by 2.6%, according to the Medicare Benefits Schedule news notice.
• The Australasian Sonographers Association said multiple imaging services on one referral can now be provided within 14 days, replacing a seven-day limit.
• Planned written consent rules for bulk-billed services were deferred, with verbal consent accepted until at least 30 June 2027.

January 2026 - Lung Cancer Screening Enrolments Approach 50,000

• On 16 January 2026 the Royal Australian College of General Practitioners reported 49,473 enrolments by mid-December 2025.
• Around 5,000 patients were flagged for more frequent follow-up screening and 560 needed immediate further investigation.
• The programme began in July 2025 and uses targeted low-dose CT for adults aged 50 to 70 with a smoking history.

Key Insight

Screening programmes, spectral technology and provider consolidation expand scanner demand and concentrate buying power. Indexed fees and faster follow-up imaging give providers confidence to invest.

Recent Market Developments in the Australia Computed Tomography Market

Recent developments, presented from the most recent, show the Australia computed tomography market moving through provider earnings, vendor launches, policy changes and multi-site scanner rollouts.

August 2026 - Integral Diagnostics Reports Higher Revenue and CT Growth

• On 25 August 2026 Integral Diagnostics reported revenue up 25.6% to AUD 788.7 million, with higher-value CT, MRI and PET services growing.
• The group said more than AUD 14 million of annual synergies from the Capitol Health merger had been realised.
• It expects capital expenditure of AUD 50 million to AUD 60 million for replacement and growth.

April 2026 - Canon Launches a Domestic Photon-Counting CT in Japan

• On 9 April 2026 Canon announced the Ultimion photon-counting CT, with a launch in Japan on 17 April 2026.
• The system uses a cadmium zinc telluride detector to deliver ultra-high resolution and spectral images in a single scan.
• Canon states the system is not available for sale outside Japan, so Australian availability is not yet confirmed.

November 2025 - Philips and Lumus Imaging Roll Out Six CT 5300 Scanners

• On 27 November 2025 Philips Australia announced six CT 5300 scanners across Lumus Imaging sites in Queensland and Peninsula Private Hospital.
• The Ipswich and Meadowbrook units use the full cardiac imaging package, described as the first in the region with that package.
• The partnership also supports the National Lung Cancer Screening Program.

August 2025 - I-MED Radiology Divests Its Jones Radiology Shareholding

• On 15 August 2025 I-MED Radiology announced the divestment of its shareholding in Jones Radiology.
• The move reshapes ownership in South Australian imaging, where Jones Radiology operates multiple sites.
• Ownership changes can reset equipment replacement plans, preferred supplier panels and service contract terms across a provider network.

Key Insight

Providers are investing in scanners and software while ownership changes and vendor launches reshape competition. Spectral technology moves from research sites into everyday private practice.

Australia Computed Tomography Industry Segmentation

The Expert Market Research’s report on the Australia Computed Tomography Market offers a detailed analysis of the market based on the following segments.

Market Breakup by Slice Type

• Up to 64-Slice
• 65 to 128-Slice
• Above 128-Slice
• Photon-Counting
• Others

65 to 128-Slice systems lead revenue, as Philips placed six CT 5300 scanners with Lumus Imaging in Queensland in November 2025. Up to 64-Slice units serve regional hospitals, smaller practices and replacement of older machines. Above 128-Slice platforms support high-volume cardiac and trauma work. Photon-Counting grows fastest at an estimated 11.6% CAGR, after Lumus Imaging opened photon-counting CT at Knox Private Hospital in August 2026 and GE HealthCare gained European certification for its Photonova Spectra system on 31 August 2026.

Market Breakup by Application

• Oncology
• Cardiovascular
• Neurology
• Musculoskeletal and Trauma
• Others

Oncology leads revenue, supported by lung cancer screening, which began in July 2025 and had 49,473 enrolments by mid-December 2025. Cardiovascular imaging grows fastest at an estimated 7.2% CAGR as Philips installed full cardiac packages at Ipswich and Meadowbrook in November 2025. Neurology covers stroke and head injury work in emergency departments. Musculoskeletal and Trauma gains from spectral reconstructions near implants, as noted by Lumus Imaging in August 2026. Others includes abdominal, vascular and interventional guidance.

Market Breakup by End User

• Diagnostic Imaging Centres
• Public Hospitals
• Private Hospitals
• Others

Diagnostic Imaging Centres lead purchasing, with Integral Diagnostics reporting growth in CT, MRI and PET services on 25 August 2026 and planning capital expenditure of AUD 50 million to AUD 60 million. Public Hospitals buy through state tenders and respond to emergency and screening demand. Private Hospitals grow fastest at an estimated 6.4% CAGR, as Knox Private Hospital added photon-counting CT in August 2026 and Peninsula Private Hospital joined the Philips rollout. Others covers general practice-linked clinics, mobile services and research sites.

Market Breakup by Region

• New South Wales
• Victoria
• Queensland
• Western Australia
• South Australia
• Others

New South Wales dominates through the largest population and private imaging network, growing at an estimated 5.2% CAGR through 2035. Victoria follows at 5.1%, with Knox Private Hospital adding photon-counting CT in August 2026. Queensland is the fastest-growing region at an estimated 6.5%, helped by the Philips rollout announced in November 2025. Western Australia grows at 5.9% on mining-linked population growth. South Australia grows at 5.5%, where Jones Radiology ownership changed in August 2025. Others covers Tasmania, the ACT and the Northern Territory at 5.7%.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape in the Australia Computed Tomography Market

Competition combines global scanner manufacturers with local service teams, and large private imaging groups that buy at scale. Barriers include regulatory registration, clinical evidence, service coverage, software ecosystems and long-term equipment finance.

Siemens Healthineers

Siemens Healthineers, headquartered in Erlangen, Germany, supplies CT systems in Australia through its local subsidiary, from entry-level Somatom platforms to Naeotom Alpha photon-counting scanners. In March 2025 the company reported United States clearances for the Naeotom Alpha.Pro and Naeotom Alpha.Prime, widening the photon-counting range to mid-range and single-source models suited to wider hospital use. Its service engineers and applications specialists support public and private customers across the states.

GE HealthCare

GE HealthCare, headquartered in Chicago, Illinois, markets Revolution series CT scanners and cardiac software to Australian hospitals and imaging groups. In March 2026 its Photonova Spectra photon-counting CT received United States and Japanese clearance, and on 31 August 2026 it gained the CE Mark. The system uses Deep Silicon detector technology, though Australian availability has not been confirmed. GE HealthCare also supplies cardiac and dose-management software.

Philips

Philips, headquartered in Amsterdam, the Netherlands, supplies CT 5300 and other CT systems through Philips Australia in Sydney. On 27 November 2025 it announced six CT 5300 scanners with Lumus Imaging across Queensland, including two with the full cardiac imaging package at Ipswich and Meadowbrook. The partnership also supports the National Lung Cancer Screening Program. Philips also provides service contracts and informatics for hospital customers.

Canon Medical Systems

Canon Medical Systems, headquartered in Otawara, Japan, supplies Aquilion CT systems in Australia and New Zealand through a regional business. On 9 April 2026 Canon announced the Ultimion photon-counting CT for launch in Japan on 17 April 2026, using a cadmium zinc telluride detector. The company states it is not for sale outside Japan, so Australian availability remains unconfirmed. Canon also supplies service and training to regional hospitals.

Other players operating in the Australia computed tomography market include United Imaging Healthcare, Fujifilm Healthcare, Integral Diagnostics, I-MED Radiology, and Sonic Healthcare, alongside regional equipment distributors, refurbished system dealers, service providers and imaging software vendors supplying scanners and support across Australia.

Key Insight

Competition rests on image quality, service coverage, software ecosystems and financing rather than price alone. Global manufacturers hold scale, while large private imaging groups negotiate multi-site agreements.